ONCOZ — Oncozenge AB Share News
0.000.00%
Last trade - 00:00- SEK89.74m
- SEK96.49m
- SEK2.66m
Brief: Oncozenge Q3 Net Loss SEK 3.2 Million
Brief: Oncozenge Says Toxic Study With Bupivacaine Shows Good Margin Of Safety
Brief: Oncozenge Q2 Loss Widens To SEK 2.8 Mln
Brief: Oncozenge Q1 Net Loss Widens To SEK 36.1 Mln
Brief: Oncozenge Cancels Planned Patient Study With Bupizenge
Brief: Oncozenge Q4 Net Loss SEK 1.1 Million
Brief: Oncozenge Initiates Toxicity Study And Announces Modification To Clinical Plan
Brief: Oncozenge Announces Paul De Potocki New CEO
Brief: OncoZenge Q3 Net Loss SEK 0.8 Mln
Brief: Oncozenge AB - Q1 Operating Loss Sek 1.4 Million
Brief: OncoZenge Rights Issue Subscribed To 170%